Expression of cytoskeleton-associated protein 4 is related to lymphatic metastasis and indicates prognosis of intrahepatic cholangiocarcinoma patients after surgery resection.

The objective of the study was to investigate the clinical significance of CKAP4 in intrahepatic cholangiocellular carcinoma (ICC). CKAP4 expression was determined in a cohort containing 173 cases of ICC patients. We found that CKAP4 was overexpressed in the majority of ICC cases and was significantly associated with tumor size, distant metastasis, lymph node metastasis, UICC and TNM stage features. Kaplan-Meier and Cox regression data indicated that CKAP4 was correlated with favorable clinical outcome and was an independent predictor for overall survival (HR, 0.646; 95% CI, 0.463-0.900 [p=0.010]). Thus, CKAP4 may serve as a prognostic marker of ICC patients.

[1]  A. Fisher,et al.  Role of P63 (CKAP4) in binding of surfactant protein-A to type II pneumocytes. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[2]  T. Janvilisri,et al.  Prognostic value of ABCG2 in moderately and poorly differentiated intrahepatic cholangiocarcinoma , 2011, Histopathology.

[3]  I. Endo,et al.  Intrahepatic cholangiocarcinoma , 2014, Radiopaedia.org.

[4]  H. Kinoshita,et al.  Clinicopathological factors predicting outcome after resection of mass‐forming intrahepatic cholangiocarcinoma , 2001, The British journal of surgery.

[5]  Jun Zhang,et al.  Identification of CKAP4/p63 as a Major Substrate of the Palmitoyl Acyltransferase DHHC2, a Putative Tumor Suppressor, Using a Novel Proteomics Method*S , 2008, Molecular & Cellular Proteomics.

[6]  M. Choti,et al.  A Proposed Staging System for Intrahepatic Cholangiocarcinoma , 2008, Annals of Surgical Oncology.

[7]  H. Hauri,et al.  Climp-63-mediated binding of microtubules to the ER affects the lateral mobility of translocon complexes , 2007, Journal of Cell Science.

[8]  P. Steyger,et al.  CLIMP-63 is a gentamicin-binding protein that is involved in drug-induced cytotoxicity , 2010, Cell Death and Disease.

[9]  P. Provost,et al.  Regulation of human Dicer by the resident ER membrane protein CLIMP-63 , 2012, Nucleic acids research.

[10]  Y. Maehara,et al.  Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis. , 2009, Human pathology.

[11]  M. Shimada,et al.  Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma , 2001, The British journal of surgery.

[12]  Nandita Mitra,et al.  Radiation therapy is associated with improved survival in the adjuvant and definitive treatment of intrahepatic cholangiocarcinoma. , 2008, International journal of radiation oncology, biology, physics.

[13]  W. Scheithauer,et al.  Treatment and outcome of intrahepatic cholangiocellular carcinoma. , 2005, American journal of surgery.

[14]  Yoko Shibata,et al.  Mechanisms Determining the Morphology of the Peripheral ER , 2010, Cell.

[15]  Brian L Hood,et al.  CKAP4/p63 Is a Receptor for the Frizzled-8 Protein-related Antiproliferative Factor from Interstitial Cystitis Patients* , 2006, Journal of Biological Chemistry.

[16]  H. Hauri,et al.  Characterization of a novel 63 kDa membrane protein. Implications for the organization of the ER-to-Golgi pathway. , 1993, Journal of cell science.

[17]  S. Kawasaki,et al.  Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. , 2000, Surgery.

[18]  Susan K Keay,et al.  Antiproliferative factor decreases Akt phosphorylation and alters gene expression via CKAP4 in T24 bladder carcinoma cells , 2010, Journal of experimental & clinical cancer research : CR.

[19]  Quan-lin Li,et al.  Overexpression of CD151 as an adverse marker for intrahepatic cholangiocarcinoma patients , 2010, Cancer.

[20]  J. Hirabayashi,et al.  Expression of endogenous galectin-1 and galectin-3 in intrahepatic cholangiocarcinoma. , 2001, Human pathology.

[21]  D. Berry,et al.  Prognostic molecular markers in cholangiocarcinoma: a systematic review. , 2009, European journal of cancer.

[22]  A. Fisher,et al.  Identification and characterization of p63 (CKAP4/ERGIC-63/CLIMP-63), a surfactant protein A binding protein, on type II pneumocytes. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[23]  S. Todo,et al.  Number of Lymph Node Metastases Is a Significant Prognostic Factor in Intrahepatic Cholangiocarcinoma , 2005, World Journal of Surgery.

[24]  Y. Nakanuma,et al.  Reduced expression of syndecan-1 correlates with histologic dedifferentiation, lymph node metastasis, and poor prognosis in intrahepatic cholangiocarcinoma. , 2003, Human pathology.